Pathogenesis of type 2 diabetes - Implications for metformin

被引:17
作者
DeFronzo, RA [1 ]
机构
[1] Univ Texas, Hlth Sci Ctr, San Antonio, TX 78284 USA
关键词
D O I
10.2165/00003495-199958001-00008
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:29 / 30
页数:2
相关论文
共 14 条
[1]   PREDOMINANT ROLE OF GLUCONEOGENESIS IN INCREASED HEPATIC GLUCOSE-PRODUCTION IN NIDDM [J].
CONSOLI, A ;
NURJHAN, N ;
CAPANI, F ;
GERICH, J .
DIABETES, 1989, 38 (05) :550-557
[2]   Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus [J].
Cusi, K ;
Consoli, A ;
DeFronzo, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (11) :4059-4067
[3]   EFFICACY OF METFORMIN IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].
DEFRONZO, RA ;
GOODMAN, AM ;
ABELOVE, W ;
REID, E ;
PITA, J ;
CALLAHAN, M ;
JOHNSON, D ;
PELAYO, E ;
PUGH, J ;
SHANK, M ;
GARZA, P ;
HAAG, B ;
KORFF, J ;
ANGELO, A ;
IZENSTEIN, B ;
VANDERLEEDEN, M ;
CATHCART, H ;
TIERNEY, M ;
BIGGS, D ;
KARAM, J ;
NOLTE, M ;
GAVIN, L ;
ELDER, MA ;
CORBOY, J ;
THWAITE, D ;
WONG, S ;
DAVIDSON, M ;
PETERS, A ;
DUNCAN, T ;
KERCHER, S ;
FISCHER, J ;
KIPNES, M ;
RADNICK, BJ ;
ROURA, M ;
ROQUE, J ;
MONTGOMERY, C ;
COLLUM, P ;
RUST, M ;
POHL, S ;
PFEIFER, M ;
ALLWEISS, P ;
LEICHTER, S ;
LEACH, P ;
GALLINA, D ;
MUSEY, V ;
BERKOWITZ, K ;
EASTMAN, R ;
TAYLOR, T ;
DELAPENA, MS ;
ZAWADSKI, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (09) :541-549
[4]   FASTING HYPERGLYCEMIA IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS - CONTRIBUTIONS OF EXCESSIVE HEPATIC GLUCOSE-PRODUCTION AND IMPAIRED TISSUE GLUCOSE-UPTAKE [J].
DEFRONZO, RA ;
FERRANNINI, E ;
SIMONSON, DC .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1989, 38 (04) :387-395
[5]   PATHOGENESIS OF NIDDM - A BALANCED OVERVIEW [J].
DEFRONZO, RA ;
BONADONNA, RC ;
FERRANNINI, E .
DIABETES CARE, 1992, 15 (03) :318-368
[6]  
DeFronzo RA, 1997, DIABETES REV, V5, P177
[7]   THE TRIUMVIRATE - BETA-CELL, MUSCLE, LIVER - A COLLUSION RESPONSIBLE FOR NIDDM [J].
DEFRONZO, RA .
DIABETES, 1988, 37 (06) :667-687
[8]   Efficacy of metformin in type II diabetes: Results of a double-blind, placebo-controlled, dose-response trial [J].
Garber, AJ ;
Duncan, TG ;
Goodman, AM ;
Mills, DJ ;
Rohlf, JL .
AMERICAN JOURNAL OF MEDICINE, 1997, 103 (06) :491-497
[9]   METFORMIN FOR OBESE, INSULIN-TREATED DIABETIC-PATIENTS - IMPROVEMENT IN GLYCEMIC CONTROL AND REDUCTION OF METABOLIC RISK-FACTORS [J].
GIUGLIANO, D ;
QUATRARO, A ;
CONSOLI, G ;
MINEI, A ;
CERIELLO, A ;
DEROSA, N ;
DONOFRIO, F .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 44 (02) :107-112
[10]   THE METABOLIC PROFILE OF NIDDM IS FULLY ESTABLISHED IN GLUCOSE-TOLERANT OFFSPRING OF 2 MEXICAN-AMERICAN NIDDM PARENTS [J].
GULLI, G ;
FERRANNINI, E ;
STERN, M ;
HAFFNER, S ;
DEFRONZO, RA .
DIABETES, 1992, 41 (12) :1575-1586